Vivimed Labs has acquired Actavis Pharma Manufacturing’s (APMPL) solid oral dosage facility in Alathur, Tamil Nadu for Rs 122 crore. The facility, which Vivimed acquired from APMPL’s parent Actavis Holding Asia BV, has already received the US Food and Drug Administration (US FDA) approval.
Along with the facility, the company has also acquired two commercially valuable and marketable Abbreviated New Drug Applications (ANDAs) which will allow the company to generate additional revenues.
Vivimed Labs’s manufacturing unit is located at Bidar, Karnataka, where it was originally engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and bulk drugs like Ibuprofen etc.
